'''演讲人：Chenyang Xu
时间：3 月 23 号（周三）下午 3:00~5:00。
地点：邯郸校区逸夫楼 604 室
联系人：阚海斌（021-55665245， 13162736845）
Abstract:
Personalized therapies play an increasingly critical role in patient care of 21st century: Image guidance with multimodality image fusion facilitates the targeting of specific organ tissue and plays an important role in optimization of tailored interventional therapies. This talk will give an overview of my personal journey in the last decade as a researcher and technology leader in research and development of of world's first commercial image guided technology product for treating complex heart beats irregularities diseases such as Atrial Fibrillation, a disease affecting more than 33 million people worldwide. With use of multimodality image fusion of CT and MRI images to real-time intra-operative electrophysiological (EP) map, clinicians can perform minimally invasive image guided ablation safely and reliably. The resulting product has been successfully used world wide and treating hundreds of thousands of patients.The technologies developed for this application are being applied to other intervention applications such as cancer, cardiology, and neuro applications.Towards end of the talk, I will provide a personal reflection on why a close collaboration between advancement in research and advancement in development for commercial applications helps to accelerate the overall technological progress and provides a compelling and stimulating experience for all the participants in this highly international and collaborative pursuit that benefits the society at large.
Chenyang Xu earned his B.S. in computer science and engineering from the University of Science and Technology of China, M.S. and Ph.D. degrees in electrical and computer engineering from the Johns Hopkins University.
Dr. Xu joined Siemens Corporate Research in 2000 and has taken various technology leadership positions in developing the next generation medical imaging technology for diagnosis and interventional applications. He is currently the General Manager of Siemens Technology to Business Berkeley since 2010 and leads a team of venture technologists to identify promising disruptive technologies and innovative startups that address notable challenges facing both industry and society.
Dr. Xu is a Fellow of IEEE and has served as program committee member on numerous international conferences in medical imaging and computer vision. He has published over 95 scientific publications and received more than 14,000 citations. He led and contributed to over 8 new medical imaging products. He holds over 30 international patents. He serves on the Industrial Advisory Board of UC Berkeley’s Department of Electrical and Computer Engineering and the Advisory Council of the Berkeley Entrepreneurs Forum. He is a board member of the Bay Area Science and Innovation Consortium (BASIC).'''
